Inhibitor of Normal Growth (ING)
Inhibitor of Normal Growth (ING)
批准号:
8349213
负责人:
Curtis Harris
金额:
$60.13万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcetylationAgingAnimal ModelApoptosisBindingCell AgingCell MaturationChromatinDNA DamageData SetDevelopmentFamilyFamily memberGene ExpressionGerm CellsGoalsGrowthGrowth InhibitorsHDAC1 geneHistone H3HumanIn VitroIncidenceInfertilityLysineMalignant NeoplasmsMediatingMeiosisMeiotic RecombinationMusPachytene StagePatientsPhenotypePhysiologicalProtein FamilyProtein p53ProteinsRNA SplicingRoleSeminiferous tubule structureSertoli cell only syndromeSperm MotilitySpermatocytesSpermatogenesisStagingTestisTumor Suppressor ProteinsVariantcarcinogenesiscell motilitychromatin modificationinhibitor/antagonistinterestmalemembermennovelresponsesarcomasenescencesoft tissuesperm celltumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ING2 (inhibitor of growth family, member 2) is a member of the ING family of putative tumor suppressors. ING2 binds to tri-methylated lysine 4 of histone H3 (H3K4me3) to regulate chromatin modification and gene expression. ING2 also functionally interacts with the tumor suppressor protein p53 to regulate cellular senescence, apoptosis and DNA damage response in vitro, and is thus expected to modulate carcinogenesis and aging. Here we investigate the developmental and physiological functions of Ing2 through targeted germline disruption. Consistent with its abundant expression in mouse and human testes, male mice deficient for Ing2 showed abnormal spermatogenesis and were infertile. Numbers of mature sperm and sperm motility were significantly reduced in Ing2-/- mice (approximately 2% of wild type, P less than 0.0001 and approximately 10% of wild type, P less than 0.0001, respectively). Their testes showed degeneration of seminiferous tubules, meiotic arrest before pachytene stage with incomplete meiotic recombination, induction of p53, and enhanced apoptosis. This phenotype was only partially abrogated by concomitant loss of p53 in the germline. The arrested spermatocytes in Ing2 -/- testes were characterized by lack of specific HDAC1 accumulation and deregulated chromatin acetylation. The role of Ing2 in germ cell maturation may extend to human ING2 as well. Using publicly available gene expression datasets, low expression of ING2 was found in teratozoospermic sperm (greater than 3-fold reduction) and in testes from patients with defective spermatogenesis (greater than 7-fold reduction in Sertoli-cell only Syndrome). This study establishes ING2 as a novel regulator of spermatogenesis functioning through both p53- and chromatin-mediated mechanisms and suggests that an HDAC1/ING2/H3K4me3-regulated, stage-specific coordination of chromatin modifications is essential to normal spermatogenesis, and provides an animal model to study idiopathic and iatrogenic infertility in men. In addition, a bona fide tumor suppressive role of Ing2 is demonstrated by increased incidence of soft-tissue sarcomas in Ing2-/- mice.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2174/138945009788185059
发表时间:
2009-05
期刊:
Current drug targets
影响因子:
3.2
作者:
[Unoki M, Kumamoto K, Harris CC]
通讯作者:
Harris CC
DOI:
10.1371/journal.pone.0015541
发表时间:
2010-11-19
期刊:
PloS one
影响因子:
3.7
作者:
[Saito M, Kumamoto K, Robles AI, Horikawa I, Furusato B, Okamura S, Goto A, Yamashita T, Nagashima M, Lee TL, Baxendale VJ, Rennert OM, Takenoshita S, Yokota J, Sesterhenn IA, Trivers GE, Hussain SP, Harris CC]
通讯作者:
Harris CC
p53, Aging, and Cancer
-
批准号:10486868
-
项目类别:
-
资助金额:$169.67万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Biomarkers of Human Lung Cancer
-
批准号:8552870
-
项目类别:
-
资助金额:$80.32万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53 Tumor Suppressor Pathway
-
批准号:8348895
-
项目类别:
-
资助金额:$64.42万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Human Colon Cancer
-
批准号:8349216
-
项目类别:
-
资助金额:$60.13万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53, Aging, and Cancer
-
批准号:10702577
-
项目类别:
-
资助金额:$187.35万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome
-
批准号:10014704
-
项目类别:
-
资助金额:$114.78万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53, Aging, and Cancer
-
批准号:10262348
-
项目类别:
-
资助金额:$216.9万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Precision Medicine of Cancer
-
批准号:10262347
-
项目类别:
-
资助金额:$216.9万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53, Aging, and Cancer
-
批准号:9343959
-
项目类别:
-
资助金额:$152.73万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Precision Medicine of Cancer
-
批准号:10486867
-
项目类别:
-
资助金额:$254.5万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Biomarkers of Human Lung Cancer
-
批准号:8349212
-
项目类别:
-
资助金额:$60.13万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53, Aging, and Cancer
-
批准号:8763568
-
项目类别:
-
资助金额:$80.22万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Human Colon Cancer
-
批准号:8552873
-
项目类别:
-
资助金额:$80.32万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Integrative Molecular Epidemiology of Human Cancer
-
批准号:9779934
-
项目类别:
-
资助金额:$171.19万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Integrative Molecular Epidemiology of Human Cancer
-
批准号:8938159
-
项目类别:
-
资助金额:$158.6万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Inhibitor of Normal Growth (ING)
-
批准号:7733297
-
项目类别:
-
资助金额:$64.86万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Precision Medicine of Cancer
-
批准号:10926229
-
项目类别:
-
资助金额:$257.01万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Inflammation and Cancer
-
批准号:8157251
-
项目类别:
-
资助金额:$74.1万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
Biomarkers of Human Esophageal Cancer
-
批准号:8157676
-
项目类别:
-
资助金额:$74.1万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
p53 Tumor Suppressor Pathway
-
批准号:7965083
-
项目类别:
-
资助金额:$78.62万
-
财政年份:--
-
负责人:Curtis Harris
-
依托单位:
海外基金